For Indian medical device manufacturers looking to expand into international markets, securing a CDSCO Test License is a critical, legally mandated step in the product development lifecycle.
Under the Medical Devices Rules (MDR), 2017, you cannot legally manufacture even small prototype batches for export validation, design verification, or international standard testing (such as ISO 10993 biocompatibility or IEC 60601 electrical safety) without explicit regulatory clearance.
Professional regulatory consultation streamlines this bottleneck, transitioning your product smoothly from the lab to global compliance portals.
The Regulatory Framework: Form MD-12 to Form MD-13
The CDSCO Test License framework dictates that a manufacturer cannot run an unmonitored production run for non-commercial evaluation. The process requires a precise digital application track:
- The Application (Form MD-12): The formal submission made by the Indian manufacturer on the CDSCO SUGAM portal or the National Single Window System (NSWS). It details the technical specifications of the device and precisely outlines why the batch is being created.
- The License (Form MD-13): The formal permission granted by the Central Licensing Authority (headed by the DCGI). This license permits you to manufacture a strictly limited, heavily justified quantity of Class A, B, C, or D devices purely for testing, evaluation, training, or demonstration.
⚠️ Strict Non-Commercial Proviso: Devices manufactured under Form MD-13 are tightly regulated. They cannot be sold commercially in the domestic market, and every single unit must be accounted for in your disposition and testing logs.
Essential Documentation Checklist
A professional service ensures your technical dossier is audit-ready before submission to prevent costly delays or formal CDSCO queries. The baseline requirements include:
- Covering Letter & Objective: A clear statement defining the objective of the test license (e.g., “Batch required for CE marking biocompatibility testing at an accredited laboratory”).
- Device Master File (DMF) Snippet: Brief technical description, intended use, classification (Class A-D), and exact materials of construction.
- Quantity Justification: A granular breakup of the proposed manufacturing run (e.g., 50 units for destructive performance testing, 10 units for retention, 5 units for lab calibration).
- Site & Personnel Mapping: Comprehensive lists of the active manufacturing equipment, internal testing instruments, and the profiles of qualified technical personnel overseeing the run.
- Quality Management System (QMS): Documentation verifying compliance with ISO 13485 or structural alignment with schedule 5 of MDR 2017.
The Step-by-Step Engagement Workflow
Navigating the SUGAM hierarchy requires specialized handling to match government timelines. A professional service manages the end-to-end workflow:
1.Portal Onboarding & SUGAM Registration:Days 1-3.
Creation and verification of your corporate profile on the official CDSCO online portal, ensuring the correct applicant credentials are designated for the manufacturing facility.
2.Dossier Compilation & Technical Review:Days 4-10.
Drafting Form MD-12, structuring the device description, and calculating the exact, data-backed volume justification for your target international testing labs.
3.Fee Management & Submission:Day 11.
Processing the mandated government fee payments online and uploading the comprehensive documentation matrix to the licensing authority’s active queue.
4.Liaison & Query Resolution:Weeks 2-4.
Actively tracking the application status and structurally answering any Clarification Queries (queries raised by CDSCO review officers) to avoid application rejection.
5.MD-13 Issuance & Log Implementation:Final Gate.
Handing over the valid Form MD-13 license (typically valid for up to 3 years) and setting up the mandatory regulatory stock and disposition registers for your facility.
Why Professional Management Minimizes Time-to-Market
While the official CDSCO processing window is generally 30 working days, incomplete technical files, weak testing protocols, or unjustified production volumes frequently trigger bureaucratic loops that push timelines past 3 months.
Engaging specialized CDSCO consultants eliminates guesswork, matches your application parameters strictly against active Medical Device Officers’ criteria, and ensures your export validation data stands up to international standards like the EU MDR or US FDA.